Brenzavvy® presents an affordable way for your patients to improve their health. It also presents an easy way for you to improve your financial health.

A new, lower-cost SGLT2 inhibitor is now available at PBA Health. Brenzavvy is an FDA-approved medications designed to lower blood sugar levels in adults with type 2 diabetes, along with diet and exercise.

Brenzavvy remains the lowest priced sodium-glucose cotransporter 2 (SGLT2) compared to other drugs in the SGLT2 class. The price point generally makes SGLT2 therapy available for a larger number of people who otherwise might not be able to afford to start and stay on this medication, namely those who are uninsured, underinsured, or on Medicaid.

If you’d like to learn more abut Brenzavvy and how it might help your patients, download this PDF.

To order, go to your account.